XENETIC BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Warrant Issued
XENETIC BIOSCIENCES, INC. (XBIO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $2.07 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-30.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2018-03-30
- XENETIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $2.07M, a 28.59% increase from fiscal 2015.
- XENETIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2015 was $1.61M, a 570.97% increase from fiscal 2014.
- XENETIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2014 was $239.89K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|
| 2016-12-31 | $2.07M 10-K · filed 2018-03-30 | |
| 2015-12-31 | $1.61M 10-K · filed 2017-03-31 | $933.20K 10-K · filed 2016-03-30 |
| 2014-12-31 | $239.89K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |